"It concerns pharmaceutical benefits and involves around 20 million kronor," Jan Tydner, prosecutor at the Swedish Economic Crime Agency, tells SVT Stockholm.
According to the suspicions, the fraud involves licensed medicines linked to Botox. These licensed medicines are not available in regular pharmacies, which means their prices are not fixed.
The doctors and pharmacists are suspected of charging the Stockholm Region significantly higher prices than the medicines were purchased for.
Since the suspected fraud was discovered, the region has stopped payments totaling several million kronor.
The suspects were recently arrested on probable cause on suspicion of aggravated fraud and attempted aggravated fraud.
